Pharmaceutical patent analyst

Keyphrases

Publications

2024

Hermann A M Mucke
Patent Highlights April-May 2023. Pharmaceutical patent analyst (2024)
Olivia J Creemer, Stephen Garner
Proposed supplementary protection certificate legislation for medicinal products. Pharmaceutical patent analyst (2024)
Luis Villafaña-Diaz, Juan C Perez-Garcia, Diana Barron-Villaverde, Perez-Santos Martin
Patenting trends by Mexican pharmaceutical companies. Pharmaceutical patent analyst (2024)
Yash Chauhan, Kumari Neha, Sharad Wakode, Mohd Shahfaiz, Ramesh B Bodla, Kalicharan Sharma
Progression and expansion of quinoline as bioactive moiety: a patent review. Pharmaceutical patent analyst (2024)
Hermann A M Mucke
Patent highlights August-September 2023. Pharmaceutical patent analyst (2024)
Hermann A M Mucke
Patent Highlights June-July 2023. Pharmaceutical patent analyst (2024)
Kiran Kumar Bellapu, Ramesh Joga, Bharthi R Kannan, Sravani Yerram, Priya Varpe, Tejaswini Mergu, Pavan Y Vasu, Saurabh Srivastava, Sandeep Kumar
Lipid-based mesoporous silica nanoparticles: a paradigm shift in management of pancreatic cancer. Pharmaceutical patent analyst (2024)

volume 12, number 6, 2024

Olivia J Creemer, Stephen Garner
Proposed supplementary protection certificate legislation for medicinal products. Pharmaceutical patent analyst 12 (6) (2024)
Kiran Kumar Bellapu, Ramesh Joga, Bharthi R Kannan, Sravani Yerram, Priya Varpe, Tejaswini Mergu, Pavan Y Vasu, Saurabh Srivastava, Sandeep Kumar
Lipid-based mesoporous silica nanoparticles: a paradigm shift in management of pancreatic cancer. Pharmaceutical patent analyst 12 (6) (2024)
Yash Chauhan, Kumari Neha, Sharad Wakode, Mohd Shahfaiz, Ramesh B Bodla, Kalicharan Sharma
Progression and expansion of quinoline as bioactive moiety: a patent review. Pharmaceutical patent analyst 12 (6) (2024)
Hermann A M Mucke
Patent Highlights April-May 2023. Pharmaceutical patent analyst 12 (6) (2024)
Olivia J Creemer, Stephen Garner
Proposed supplementary protection certificate legislation for medicinal products. Pharmaceutical patent analyst 12 (6) (2024)
Olivia J Creemer, Stephen Garner
Proposed supplementary protection certificate legislation for medicinal products. Pharmaceutical patent analyst 12 (6) (2024)
Yash Chauhan, Kumari Neha, Sharad Wakode, Mohd Shahfaiz, Ramesh B Bodla, Kalicharan Sharma
Progression and expansion of quinoline as bioactive moiety: a patent review. Pharmaceutical patent analyst 12 (6) (2024)
Kiran Kumar Bellapu, Ramesh Joga, Bharthi R Kannan, Sravani Yerram, Priya Varpe, Tejaswini Mergu, Pavan Y Vasu, Saurabh Srivastava, Sandeep Kumar
Lipid-based mesoporous silica nanoparticles: a paradigm shift in management of pancreatic cancer. Pharmaceutical patent analyst 12 (6) (2024)
Luis Villafaña-Diaz, Juan C Perez-Garcia, Diana Barron-Villaverde, Perez-Santos Martin
Patenting trends by Mexican pharmaceutical companies. Pharmaceutical patent analyst 12 (6) (2024)
Luis Villafaña-Diaz, Juan C Perez-Garcia, Diana Barron-Villaverde, Perez-Santos Martin
Patenting trends by Mexican pharmaceutical companies. Pharmaceutical patent analyst 12 (6) (2024)
Hermann A M Mucke
Patent Highlights April-May 2023. Pharmaceutical patent analyst 12 (6) (2024)

2023

Gabriela Sánchez Esgua, Juan Reyes-Alvarez, Perez-Santos Martin
Patenting trends in the pharmaceutical field of Mexican universities . Pharmaceutical patent analyst (2023)
Ruqaiyyah Siddiqui, Naveed Ahmad Khan
Patents, pharmaceutical industry and healthcare. Pharmaceutical patent analyst (2023)
Daniel Hilton, Vicki Allen, Graham Lewis
Review of EPO Board of Appeal antibody decisions in 2022. Pharmaceutical patent analyst (2023)
Hai-Long Zhang, Qian Kong
Current landscape and future prospects of RET and ROS1 targets. Pharmaceutical patent analyst (2023)
Rami A Al-Horani
Steroid sulfatase inhibitors and sulfated C19 steroids for proteotoxicity-related diseases: a patent spotlight. Pharmaceutical patent analyst (2023)
Ruqaiyyah Siddiqui, Naveed Ahmad Khan
Contact lens disinfectants against Acanthamoeba keratitis: an overview of recent patents and future needs. Pharmaceutical patent analyst (2023)
Faiza Saleem, Fouzia Naz, Khalid Mohammed Khand
Patent analysis of novel therapeutic approaches for treating Alzheimer's disease 2018-2023. Pharmaceutical patent analyst (2023)
Ramesh Joga, Hitesh Kumar Behera, Chetan Dushant Sabanis, null Simran, Sandeep Kumar, Neeraj Kumar
Photoresponsive liposomes: an alternative of ELISA for the detection of low quantities of target substances. Pharmaceutical patent analyst (2023)
Hermann A M Mucke
Patent highlights February-March 2023. Pharmaceutical patent analyst (2023)
Hermann A M Mucke
Patent highlights August-September 2022. Pharmaceutical patent analyst (2023)
Sravani Yerram, Ramesh Joga, Pooja Shende, Priya Varpe, Kiran Kumar Bellapu, Sandeep Kumar
Prominence of bioresponsive DNA nanococoons in tackling post-surgery cancer recurrence. Pharmaceutical patent analyst (2023)
Hermann A M Mucke
Patent highlights October-November 2022. Pharmaceutical patent analyst (2023)
Anuradha Mehra, Rekha Sangwan, Aryan Mehra, Shivani Sharma, Pankaj Wadhwa, Amit Mittal
Therapeutic charisma of imidazo [2,1-b] [1,3,4]-thiadiazole analogues: a patent review. Pharmaceutical patent analyst (2023)
Hai-Long Zhang, Qian Kong
Patent landscape of platelet growth factor receptor and c-KIT targets. Pharmaceutical patent analyst (2023)
Palak Rani, Vikas Yadav, Parijat Pandey, Kiran Yadav
Recent patent-based review on the role of three-dimensional printing technology in pharmaceutical and biomedical applications. Pharmaceutical patent analyst (2023)
Hermann A M Mucke
Patent highlights December 2022-January 2023. Pharmaceutical patent analyst (2023)
Nemesio Villa-Ruano, Vianey Marin-Cevada, Gabriela Sánchez Esgua, Luis Villafaña-Diaz, Perez-Santos Martin
Drug repurposing of rimantadine for treatment of cancer. Pharmaceutical patent analyst (2023)
Vikas Yadav, Rubina Islam, Hardeep Singh Tuli
Patent landscape highlighting double-edged scaffold of a WNT5A-agonizing peptide, Foxy5. Pharmaceutical patent analyst (2023)
Ricardo S Porto, Viviane A Porto
Morita-Baylis-Hillman adducts and their derivatives: a patent-based exploration of diverse biological activities. Pharmaceutical patent analyst (2023)
Rami A Al-Horani
Riluzole and its prodrugs for the treatment of Alzheimer's disease. Pharmaceutical patent analyst (2023)
Nemesio Villa-Ruano, Maricruz Anaya-Ruiz, Luis Villafaña-Diaz, Diana Barron-Villaverde, Perez-Santos Martin
Drug repurposing of Mito-Atovaquone for cancer treatment. Pharmaceutical patent analyst (2023)
Narayanasamy Kumutha, Narayanasamy Amutha, Govindasamy S Venkatesh
Compulsory licensing of patents. Pharmaceutical patent analyst (2023)
Irene von der Weid, Cristina d'Urso de Souza Mendes Santos, Paula C Fonseca, Sandro G Viveiros Rosa
Patent profile for the approved and in clinical trials Mpox vaccines. Pharmaceutical patent analyst (2023)

volume 12, number 5, 2023

Sukhbir K Shahid
Recent patents in the treatment and prevention of leishmaniasis. Pharmaceutical patent analyst 12 (5) (2023)

volume 11, number 6, 2023

Michael Bell, Runjhun Tandon
Papers from the First International Conference on Innovation and Intellectual Property Rights. Pharmaceutical patent analyst 11 (6) (2023)
Narayanasamy Kumutha, Narayanasamy Amutha, Govindasamy S Venkatesh
Compulsory licensing of patents. Pharmaceutical patent analyst 11 (6) (2023)
Narayanasamy Kumutha, Narayanasamy Amutha, Govindasamy S Venkatesh
Compulsory licensing of patents. Pharmaceutical patent analyst 11 (6) (2023)
Narayanasamy Kumutha, Narayanasamy Amutha, Govindasamy S Venkatesh
Compulsory licensing of patents. Pharmaceutical patent analyst 11 (6) (2023)

volume 11, number 5, 2022

Ramesh Joga, Christy J Pulini-Kunnel, Chetan D Sabanis, null Simran, Sandeep Kumar, Neeraj Kumar
Highly stable, non-toxic and functionalized nanoemulsion for the early diagnosis and amelioration of cancer. Pharmaceutical patent analyst 11 (5) (2022)

volume 11, number 6, 2022